Symptomatic hyponatremia in patients on oxcarbazepine therapy for the treatment of neuropathic pain: Two case reports

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 17, Issue 1, 2003, Pages 47-51

  Adkoli, Sujnani ^a,b  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH HOSPITAL   (United States)

Author keywords

Hyponatremia; Neuropathic pain; Oxcarbazepine

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CITALOPRAM; DESIPRAMINE; OXCARBAZEPINE; SERTRALINE; SODIUM; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BACKACHE; BEHAVIOR MODIFICATION; CASE REPORT; ELECTROMYOGRAPHY; FEMALE; HUMAN; HYPONATREMIA; NEUROPATHIC PAIN; NEUROPATHY; PHYSIOTHERAPY; SOMNOLENCE;

EID: 0037256014     PISSN: 15360288     EISSN: None     Source Type: Journal    
DOI: 10.1080/J354v17n01_06     Document Type: Article

References (10)

1. Zakrzewska JM, Patsalos PN. Drugs used in the management of trigeminal neuralgia. Oral Surg Oral Med Oral Pathol. 1992 Oct;74(4):439-50. Review.
2. Zakrzewska JM, Patsalos PN. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):472-6.
3. Farago F. Trigeminal neuralgia: its treatment with two new carbamazepine analogues. Eur Neurol. 1987;26(2):73-83.
4. Wallace MS. Pharmacologic treatment of neuropathic pain. Current Pain and Headache Reports. 2001;5:138-150.
5. Galer BS. Painful polyneuropathy. Neurologic Clinics, 1998;16(4):791-812.
6. Trileptal package labeling. 〈http://www.pdr.net〉. Accessed July, 2002.
7. Ichikawa K, Koyama N, Kiguchi S, Kojima M, Yokota T. Inhibitory effect of oxcarbezepine on high frequency firing in peripheral nerve. Eur J Pharmacol. 2001 May 25;420(2-3):119-22.
8. Kiguchi S, Ihikawa K, Kojima M. Suppressive effects of oxcarbazepine on tooth pulp-evoked potentials recorded in trigeminal spinal tract nucleus in cats. Clin Exp Pharmacol Physiol. 2001;28(3):169-75.
9. Tegretol package labeling. 〈http://www.pdr.net〉. Accessed July, 2002.
10. Jouko IT, Isojarvi UE, Huuskonen J, Pakarinen AJ, Vuolteenaho O, Myllyla V. The regulation of serum sodium after replacing carbamazepine with oxcarbezepine. Epilepsia. 2001;42(6):741-45.